Vitamin D as a novel nontraditional risk factor for mortality in hemodialysis patients: the need for randomized trials.
Vitamin D as a novel nontraditional risk factor for mortality in hemodialysis patients: the need for randomized trials.
复制标题
DOI：
10.1038/sj.ki.5002544
复制
发表时间：
2007-10
影响因子：
19.6
通讯作者：
Z. Al‐Aly
中科院分区：
文献类型：
--
作者：
Z. Al‐Aly
维生素D已用于终末期肾病患者继发性甲状旁腺功能亢进的背景下。最近的一系列研究表明，维生素D治疗可能与这些患者的死亡风险降低有关。Wolfet等人的文章通过确定维生素D缺乏是血液透析患者早期死亡的危险因素，进一步支持了这些研究。
Vitamin D has been used in the context of secondary hyperparathyroidism in patients with end-stage renal disease. A wave of recent studies suggests that vitamin D treatment may be associated with decreased mortality risk in these patients. The article by Wolfet al.further supports these studies by identifying vitamin D deficiency as a risk factor for early mortality in incident hemodialysis patients.